Mongodb Inc vs State Street SPDR S&P Biotech ETF — how do they compare? Mongodb Inc trades at $308 (market cap $26.01B), while State Street SPDR S&P Biotech ETF trades at $154.49. The key difference: State Street SPDR S&P Biotech ETF is trading nearer its 52-week high, Mongodb Inc nearer its low. Which is the better fit depends on your goals.
| MDB | XBI | |
|---|---|---|
Market Cap | $26.01B | — |
Sector | Technology | Broad Market / Factor |
52-Week High | $440.25 | $164.28 |
52-Week Low | $201.08 | $85.16 |
Enterprise Value | $23.61B | — |
Trailing returns across standard periods
Latest headlines on both assets
Founded in 2007, MongoDB is a document-oriented database with nearly 33,000 paying customers and well past 1.5 million free users. MongoDB provides both licenses as well as subscriptions as a service for its NoSQL database. MongoDB's database is compatible with all major programming languages and is capable of being deployed for a variety of use cases.
Read more on MDB →XBI is an equal-weighted ETF that tracks the U.S. biotechnology segment. It provides diversified exposure to small, mid, and large-cap biotech firms involved in drug discovery and medical research, such as Moderna and Exact Sciences.
Read more on XBI →